Pre-operative Nomogram to Predict Risk of Peri-operative Mortality following Liver Resections for Malignancy
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The majority of liver resections for malignancy are performed in older patient with major co-morbidities. There is currently no pre-operative, patient-specific method to determine the likely peri-operative mortality for each individual patient. The aim of this study was to develop a pre-operative nomogram based on the presence of co-morbidities to predict risk of peri-operative mortality following liver resections for malignancy.
The Nationwide Inpatient Sample database was queried to identify adult patients that underwent liver resection for malignancy. The pre-operative co-morbidities, identified as predictors were used and a nomogram was created with multivariate regression using Taylor expansion method in SAS software, SURVEYLOGISTIC procedure. Training set (years 2000–2004) was utilized to develop the model and validation set (year 2005) was utilized to validate this model.
A total of 3,947 and 972 patients were included in training and validation sets, respectively. The overall actual-observed peri-operative mortality rates for training and validation sets were 4.1% and 3.2%, respectively. The decile-based calibration plots for the training set revealed good agreement between the observed probabilities and nomogram-predicted probabilities. Similarly, the quartile-based calibration plot for the validation set revealed good agreement between the observed and predicted probabilities. The accuracy of the nomogram was further reinforced by a good concordance index of 0.80 with a 95% confidence interval of 0.72 and 0.87.
This pre-operative nomogram may be utilized to predict the risk of peri-operative mortality following liver resection for malignancy.
- Dimick JB, Wainess RM, Cowan JA, Upchurch GR, Jr., Knol JA, Colletti LM. National trends in the use and outcomes of hepatic resection. J Am Coll Surg 2004;199:31-8. CrossRef
- Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002;236:397–406; discussion -7. CrossRef
- de Baere T, Denys A, Madoff DC. Preoperative portal vein embolization: indications and technical considerations. Tech Vasc Interv Radiol 2007;10:67–78. CrossRef
- Adam R, Miller R, Pitombo M, Wicherts DA, de Haas RJ, Bitsakou G, Aloia T. Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. Surg Oncol Clin N Am 2007;16:525–36, viii. CrossRef
- Garrean S, Hering J, Saied A, Helton WS, Espat NJ. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 2008;195:508–20. CrossRef
- Lencioni R, Crocetti L. Radiofrequency ablation of liver cancer. Tech Vasc Interv Radiol 2007;10:38–46. CrossRef
- Adam R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol 2003;14 Suppl 2:ii13–6. CrossRef
- Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008;13:51–64. CrossRef
- Vauthey JN, Zorzi D, Pawlik TM. Making unresectable hepatic colorectal metastases resectable—does it work? Semin Oncol 2005;32:S118–22. CrossRef
- Cescon M, Vetrone G, Grazi GL, Ramacciato G, Ercolani G, Ravaioli M, Del Gaudio M, Pinna AD. Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg 2009;249:995–1002. CrossRef
- Virani S, Michaelson JS, Hutter MM, Lancaster RT, Warshaw AL, Henderson WG, Khuri SF, Tanabe KK. Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg 2007;204:1284–92. CrossRef
- Asiyanbola B, Chang D, Gleisner AL, Nathan H, Choti MA, Schulick RD, Pawlik TM. Operative mortality after hepatic resection: are literature-based rates broadly applicable? J Gastrointest Surg 2008;12:842–51. CrossRef
- Glasgow RE, Showstack JA, Katz PP, Corvera CU, Warren RS, Mulvihill SJ. The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg 1999;134:30–5. CrossRef
- Ston ME, Jr., Rehman SU, Conaway G, Sardi A. Hepatic resection at a community hospital. J Gastrointest Surg 2000;4:349–53; discussion 53–4. CrossRef
- Ra J, Paulson EC, Kucharczuk J, Armstrong K, Wirtalla C, Rapaport-Kelz R, Kaiser LR, Spitz FR. Postoperative mortality after esophagectomy for cancer: development of a preoperative risk prediction model. Ann Surg Oncol 2008;15:1577–84. CrossRef
- Simons JP, Hill JS, Ng SC, Shah SA, Zhou Z, Whalen GF, Tseng JF. Perioperative mortality for management of hepatic neoplasm: a simple risk score. Ann Surg 2009;250:929–34. CrossRef
- Simons JP, Ng SC, Hill JS, Shah SA, Bodnari A, Zhou Z, Tseng JF. In-hospital mortality for liver resection for metastases: a simple risk score. J Surg Res 2009;156:21–5. CrossRef
- Simons JP, Ng SC, Hill JS, Shah SA, Zhou Z, Tseng JF. In-hospital mortality from liver resection for hepatocellular carcinoma: a simple risk score. Cancer 2010;116:1733–8 CrossRef
- Are C, Afuh C, Ravipati L, Sasson A, Ullrich F, Smith L. Preoperative nomogram to predict risk of perioperative mortality following pancreatic resections for malignancy. J Gastrointest Surg 2009;13:2152–62. CrossRef
- Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8–27. CrossRef
- Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, Takayama T, Makuuchi M. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003;138:1198–206; discussion 206. CrossRef
- Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, Kubota K, Zucchi A. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999;134:984–92. CrossRef
- Yanaga K, Wakasugi K, Matsusaka T, Kume H. Hepatic resection without mortality at a community hospital. Int Surg 2003;88:87–91.
- (No author’s listed) Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators. Hepatology 2000;31:840–5.
- Green FL PD, Fleming ID et. al. American Joint Committee on Cancer. Liver (including intrahepatic bile ducts). In: Frederick L. Greene CMB, Daniel G. Haller, Monica Morrow. AJCC Cancer Staging Handbook, 6th ed. New York: Springer, 2002:131–44.
- Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 2003;38:207–15. CrossRef
- Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329–38. CrossRef
- Delis SG, Bakoyiannis A, Dervenis C, Tassopoulos N. Perioperative risk assessment for hepatocellular carcinoma by using the MELD score. J Gastrointest Surg 2009;13:2268–75. CrossRef
- Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, Lok AS. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 2005;41:707–16. CrossRef
- Schroeder RA, Marroquin CE, Bute BP, Khuri S, Henderson WG, Kuo PC. Predictive indices of morbidity and mortality after liver resection. Ann Surg 2006;243:373–9. CrossRef
- Kattan MW. The many uses of cancer prediction tools. Semin Oncol 2010;37:20–2. CrossRef
- Kattan MW, Marasco J. What is a real nomogram? Semin Oncol 2010;37:23–6. CrossRef
- Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008;359:1018–26. CrossRef
- Samuel D. MELD-Na as a prognostic score for cirrhotic patients: Hyponatremia and ascites are back in the game. J Hepatol 2009;50:836–8. CrossRef
- Pre-operative Nomogram to Predict Risk of Peri-operative Mortality following Liver Resections for Malignancy
Journal of Gastrointestinal Surgery
Volume 14, Issue 11 , pp 1770-1781
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Liver resections
- Peri-operative mortality
- Industry Sectors
- Author Affiliations
- 1. Division of Surgical Oncology, Eppley Cancer Center, Department of Surgery, University of Nebraska Medical Center, Omaha, NE, USA
- 2. Department of Epidemiology and Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, NE, USA
- 3. Division of Surgical Oncology, Department of Surgery/Genetics, Cell Biology and Anatomy, Associate Program Director, General Surgery Residency, University of Nebraska Medical Center, Omaha, NE, 68198, USA